|
|
PUT
|
$212,000
|
55.8K
|
Q3 2025
Added 463.64%
|
|
|
|
CALL
|
$762,000
|
161K
|
Q3 2025
Reduced 10.49%
|
|
|
|
PUT
|
$878,000
|
186K
|
Q3 2025
Added 29.59%
|
|
|
|
CALL
|
$19,000
|
2.3K
|
Q3 2025
Reduced 87.22%
|
|
|
|
|
|
PUT
|
$91,000
|
10.8K
|
Q3 2025
Reduced 50.91%
|
|
Evolv Technologies Hldngs In
|
CALL
|
$1.52 Million
|
201K
|
Q3 2025
Reduced 13.28%
|
|
Evolv Technologies Hldngs In
|
PUT
|
$5.6 Million
|
742K
|
Q3 2025
Added 70.25%
|
|
|
|
CALL
|
$67,000
|
200
|
Q3 2025
Reduced 93.94%
|
|
|
|
PUT
|
$134,000
|
400
|
Q3 2025
Reduced 71.43%
|
|
|
|
CALL
|
$288,000
|
3.8K
|
Q3 2025
Reduced 40.63%
|
|
|
|
PUT
|
$30,000
|
400
|
Q3 2025
Reduced 63.64%
|
|
|
|
CALL
|
$441,000
|
85.1K
|
Q3 2025
New holding
|
|
|
|
PUT
|
$208,000
|
40.1K
|
Q3 2025
Added 718.37%
|
|
Edwards Lifesciences Corp
|
PUT
|
$5.82 Million
|
74.8K
|
Q3 2025
Reduced 45.04%
|
|
|
|
CALL
|
$479,000
|
4.5K
|
Q3 2025
Reduced 18.18%
|
|
|
|
PUT
|
$10,000
|
100
|
Q3 2025
Reduced 75.0%
|
|
|
|
|
|
PUT
|
$73,000
|
18.4K
|
Q3 2025
New holding
|
|
Edgewise Therapeutics Inc
|
CALL
|
$32,000
|
2K
|
Q3 2025
Added 66.67%
|
|
Edgewise Therapeutics Inc
|
PUT
|
$50,000
|
3.1K
|
Q3 2025
Reduced 80.98%
|
|
|
|
CALL
|
$968,000
|
28.8K
|
Q3 2025
Reduced 47.54%
|
|
|
|
PUT
|
$4.97 Million
|
133K
|
Q3 2025
Reduced 23.15%
|
|
|
|
CALL
|
$5.76 Million
|
105K
|
Q3 2025
Added 59.15%
|
|
|
|
PUT
|
$3.53 Million
|
64.5K
|
Q3 2025
Added 9.14%
|
|
|
|
CALL
|
$3.38 Million
|
75K
|
Q3 2025
Reduced 30.94%
|
|
|
|
PUT
|
$2.62 Million
|
58.3K
|
Q3 2025
Reduced 62.72%
|
|
Expand Energy Corporation
|
PUT
|
$9.02 Million
|
84.9K
|
Q3 2025
Reduced 22.32%
|
|
|
|
CALL
|
$3.84 Million
|
92.9K
|
Q3 2025
Reduced 17.5%
|
|
|
|
PUT
|
$3.35 Million
|
81.1K
|
Q3 2025
Reduced 31.27%
|
|
|
|
CALL
|
$18,000
|
10.1K
|
Q3 2025
New holding
|
|
|
|
CALL
|
$5.31 Million
|
677K
|
Q3 2025
Added 138.19%
|
|
|
|
PUT
|
$671,000
|
85.7K
|
Q3 2025
Reduced 25.15%
|
|
|
|
CALL
|
$981,000
|
22.3K
|
Q3 2025
Reduced 42.82%
|
|
|
|
PUT
|
$8,000
|
200
|
Q3 2025
Reduced 85.71%
|
|
|
|
CALL
|
$396,000
|
1.7K
|
Q3 2025
Added 13.33%
|
|
|
|
PUT
|
$46,000
|
200
|
Q3 2025
Added 100.0%
|
|
|
|
CALL
|
$723,000
|
5.9K
|
Q3 2025
Added 1866.67%
|
|
|
|
PUT
|
$85,000
|
700
|
Q3 2025
Reduced 36.36%
|
|
|
|
CALL
|
$536,000
|
50.3K
|
Q3 2025
Added 993.48%
|
|
|
|
PUT
|
$90,000
|
8.5K
|
Q3 2025
Reduced 24.11%
|
|
|
|
PUT
|
$6,000
|
100
|
Q2 2025
Reduced 90.0%
|
|
|
|
CALL
|
$676,000
|
4.8K
|
Q3 2025
Added 65.52%
|
|
|
|
PUT
|
$183,000
|
1.3K
|
Q3 2025
Added 30.0%
|
|
|
|
CALL
|
$280,000
|
13.6K
|
Q3 2025
Reduced 61.36%
|
|
|
|
PUT
|
$72,000
|
3.5K
|
Q3 2025
Reduced 32.69%
|
|
National Vision Hldgs Inc
|
CALL
|
$14,000
|
500
|
Q3 2025
Reduced 98.34%
|
|
National Vision Hldgs Inc
|
PUT
|
$55,000
|
1.9K
|
Q3 2025
Reduced 86.33%
|
|
Eyepoint Pharmaceuticals Inc
|
CALL
|
$351,000
|
24.7K
|
Q3 2025
Reduced 32.7%
|
|
Eyepoint Pharmaceuticals Inc
|
PUT
|
$484,000
|
34K
|
Q3 2025
Reduced 71.04%
|
|
|
|
CALL
|
$898,000
|
47.2K
|
Q3 2025
Added 661.29%
|
|
|
|
PUT
|
$976,000
|
51.3K
|
Q3 2025
Added 93.58%
|
|